# US Single-Photon Emission Computed Tomography Market > US Single Photon Emission Computed Tomography Market Research Report: Size, Share, Trend Analysis By Types (Hybrid SPECT Systems, Standalone SPECT System), By Applications (Oncology, Cardiology, Neurology) and By End Users (Hospitals, Diagnostic Imaging Centers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.9% - **2024:** $ 419.06 Million - **2025:** $ 447.98 Million - **2035:** $ 873.21 Million - **Key Players:** Siemens Healthineers (DE), GE Healthcare (GB), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Mediso Medical Imaging Systems (HU), Spectrum Dynamics Medical (US), Zebra Medical Vision (IL) **Report ID:** MRFR/HC/18178-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-single-photon-emission-computed-tomography-market-19725 --- ## Market Summary ## **US Single Photon Emission Computed Tomography Market Overview** As per MRFR analysis, the US Single Photon Emission Computed Tomography Market Size was estimated at 391.91 (USD Million) in 2023. The US Single Photon Emission Computed Tomography Market Industry is expected to grow from 420(USD Million) in 2024 to 880 (USD Million) by 2035. The US Single Photon Emission Computed Tomography Market CAGR (growth rate) is expected to be around 6.955% during the forecast period (2025 - 2035). ### **Key US Single Photon Emission Computed Tomography Market Trends Highlighted** The US Single Photon Emission Computed Tomography (SPECT) market is witnessing significant growth, driven primarily by the rising prevalence of chronic diseases and advancements in medical imaging technology. Increased investments in healthcare infrastructure and an aging population contribute to the demand for more efficient diagnostic tools. The integration of SPECT with other imaging modalities, such as computed tomography and magnetic resonance imaging, is enhancing diagnostic accuracy, thus acting as a key market driver. Furthermore, there is a growing emphasis on personalized medicine and patient-centric approaches, which are pushing for the development of advanced SPECT imaging agents that can provide more specific and effective insights into patient conditions. Opportunities in the US market are being expanded by the ongoing research and development in radiopharmaceuticals, which can improve the efficacy of SPECT imaging. Government initiatives aimed at boosting healthcare access could provide a boost to market growth by encouraging the adoption of SPECT technology across various healthcare settings, including outpatient facilities and specialized clinics. The advent of artificial intelligence and machine learning in analyzing imaging data also presents opportunities for further enhancements in diagnostic processes, making imaging faster and more reliable. In recent times, there has been a trend towards the introduction of portable and mobile SPECT systems, which facilitate easier access to imaging services in various settings, including rural areas. Additionally, collaborations among healthcare providers, technology developers, and academic institutions are fostering innovations that benefit the market. The emphasis is on enhancing workflow efficiency and reducing operational costs while providing accurate diagnostic solutions tailored to patient needs, which aligns with the broader trends of improving healthcare delivery in the US. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Single Photon Emission Computed Tomography Market Drivers** ### **Increasing Incidence of Cancer and Other Chronic Diseases** The increasing incidence of cancer and other chronic diseases in the United States serves as a significant driver for the US [Single Photon Emission Computed Tomography Market](../../../reports/single-photon-emission-computed-tomography-market-7231) Industry. According to the American Cancer Society, it is estimated that in 2023 there will be over 1.9 million new cancer cases diagnosed in the US alone. This rising patient population is prompting healthcare providers to invest in advanced imaging technologies, including Single Photon Emission Computed Tomography (SPECT), which aids in the early detection and treatment planning of various cancers. Additionally, the National Institutes of Health highlight that heart diseases are also major contributors to mortality in the US, increasing the demand for diagnostic imaging tools. The emphasis on early diagnosis and non-invasive imaging methods is crucial, as organizations like the Food and Drug Administration work toward approving advanced imaging solutions to cater to this growing need. ### **Technological Advancements in Imaging Techniques** Technological advancements in imaging techniques are a crucial market driver for the US Single Photon Emission Computed Tomography Market Industry. Approximately 70% of SPECT systems are being upgraded or replaced with digital detectors and improved software that provide enhanced image quality and diagnostic capabilities. Major companies such as GE Healthcare and Siemens Healthineers are continuously innovating in this space, leading to the development of advanced SPECT systems that provide better accuracy in diagnosing cardiovascular diseases and neurological conditions. These advancements are not only improving patient outcomes but also increasing the operational efficiency of healthcare facilities, thereby contributing to market growth. ### **Growing Government Initiatives and Funding for Medical Imaging** Growing government initiatives and funding for medical imaging are catalyzing growth in the US Single Photon Emission Computed Tomography Market Industry. The Centers for Medicare & Medicaid Services (CMS) in the US have increased funding for advanced imaging services, recognizing the value of SPECT in improving diagnostic accuracy. With estimated funding for medical imaging services projected to exceed USD 50 billion annually, the potential for widespread adoption of SPECT technology is significant. Furthermore, initiatives aimed at promoting early diagnosis and health awareness are driving healthcare providers to incorporate advanced imaging modalities into their practices, reflecting a commitment to enhancing patient care through technology. ## **US Single Photon Emission Computed Tomography Market Segment Insights** ### **Single Photon Emission Computed Tomography Market Type Insights** The US Single Photon Emission Computed Tomography Market demonstrates a dynamic landscape shaped by its distinct Type segment, which includes Hybrid SPECT Systems and Standalone SPECT Systems. The market is experiencing considerable growth due to the increasing incidence of cancer and cardiovascular diseases, necessitating advanced imaging techniques for accurate diagnostics. Hybrid SPECT Systems, which combine traditional SPECT with other imaging modalities, are gaining prominence due to their ability to provide improved diagnostic accuracy and enhanced functional imaging capabilities. This integration allows for the simultaneous acquisition of anatomical and functional information, making it an essential tool in personalized medicine and treatment planning. Meanwhile, Standalone SPECT Systems continue to hold a significant share of the market owing to their reliability and widespread use in a variety of clinical settings. These systems are particularly valued for their cost-effectiveness and ease of use, making them accessible in numerous healthcare facilities across the US. The opportunity for innovation within these systems is also driving advancements in detector technology and image reconstruction algorithms, further enhancing image quality and patient outcomes. The demand for non-invasive imaging and the need for efficient diagnosis will likely sustain the growth of both Hybrid and Standalone SPECT Systems. Additionally, advancements in software solutions and integration with artificial intelligence are expected to further augment the capabilities and utility of SPECT imaging, aligning with the broader trends in healthcare focused on technological integration and patient-centered care. Overall, the Type segment of the US Single Photon Emission Computed Tomography Market is marked by diverse offerings, each catering to specific clinical needs while collectively contributing to the evolution of diagnostic imaging practices in the region. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Single Photon Emission Computed Tomography Market Application Insights** The US Single Photon Emission Computed Tomography Market, particularly within the Application segment, has shown considerable advancement and diversification. This segment includes essential areas such as Oncology, Cardiology, and Neurology, which play a crucial role in the overall landscape of imaging technology. Oncology has gained prominence due to the increasing prevalence of cancer in the US, driving demand for diagnostic methods that can provide more precise imaging for tumor evaluation and treatment planning. Similarly, Cardiology benefits significantly from Single Photon Emission Computed Tomography, enabling physicians to assess heart function and detect conditions such as coronary artery disease with high accuracy. Neurology also merits attention, as this sector utilizes advanced imaging to diagnose and monitor neurological disorders like Alzheimer's disease and epilepsy, thus underscoring the importance of functional imaging in understanding brain activity. Overall, the US Single Photon Emission Computed Tomography Market segmentation reflects a robust framework that caters to critical healthcare needs, with each application area contributing to improved patient outcomes and driving the demand for innovative imaging solutions. ### **Single Photon Emission Computed Tomography Market End User Insights** The US Single Photon Emission Computed Tomography Market showcases significant segmentation within the end user domain, primarily focusing on Hospitals and Diagnostic Imaging Centers. Hospitals play a pivotal role in the utilization of Single Photon Emission Computed Tomography due to the essential diagnostic capabilities it offers for various diseases, especially in nuclear medicine, oncology, and cardiac studies. The advanced imaging technology allows healthcare professionals to assess organ functions and detect conditions at earlier stages, contributing to improved patient outcomes. Diagnostic Imaging Centers also hold a critical position in this market, providing specialized imaging services that are increasingly sought after for outpatient care. The growing demand for non-invasive diagnostic procedures in the US healthcare system drives the adoption of Single Photon Emission Computed Tomography in these centers, reinforcing their importance in diagnostic workflows. As healthcare providers continually seek to enhance diagnostic precision, the focus on these end users is vital, as they are integral in facilitating early diagnosis and improving patient management strategies. Overall, the dual emphasis on Hospitals and Diagnostic Imaging Centers not only reflects the expanding role of imaging technology in modern medicine but also illustrates the dynamic landscape of the US Single Photon Emission Computed Tomography Market. ## **US Single Photon Emission Computed Tomography Market Key Players and Competitive Insights** The US Single Photon Emission Computed Tomography Market showcases a dynamic landscape characterized by noteworthy technological advancements and a growing demand for enhanced diagnostic imaging solutions. The competition within this market is fueled by the increase in chronic disease prevalence and the rising importance of precise diagnostic tools in clinical settings. Players in this sector are innovating their product offerings while also focusing on strategic partnerships, research and development, and regulatory compliance to maintain a competitive edge. The market dynamics are influenced by various factors such as pricing strategy, product differentiation, geographical presence, and distribution channels, leading to an evolving competitive environment where both established and emerging companies vouch for market share. ### **Key Company Analysis** #### **MediLumine** MediLumine stands out in the US Single Photon Emission Computed Tomography Market by leveraging its strong portfolio of imaging technologies designed to cater to the specific needs of healthcare providers. The company has carved a niche by focusing on the development of highly sensitive and efficient imaging systems that enhance diagnostic accuracy. MediLumine's commitment to customer-focused service provision, along with a robust supply chain, has reinforced its visibility in the market. Not only does it boast an established presence in clinical settings across the United States, but the company also prioritizes user training and support, which further solidifies its reputation among healthcare professionals. This strategic emphasis on comprehensive solutions and services contributes to MediLumine's competitive advantage in a market that continuously seeks innovation and reliability. #### **Koninklijke Philips N.V.** Koninklijke Philips N.V. holds a significant position in the US Single Photon Emission Computed Tomography Market, recognized for its comprehensive range of advanced imaging equipment and healthcare solutions. The company excels in delivering state-of-the-art SPECT systems that optimize image quality while enhancing patient care and operational efficiencies for healthcare providers. Its strengths include a substantial investment in research and development, which fosters continuous innovation in imaging technology. Philips has also maintained a strong market presence through strategic collaborations and acquisitions, enabling it to expand its product offerings and improve market access. The company’s focus on integrating imaging systems with healthcare IT solutions reinforces its competitive stance, as it aligns with the increasing trend toward data-driven healthcare. By offering a diverse range of solutions, including advanced analytics and after-sales support, Koninklijke Philips N.V. enhances its proposition to customers in the US market. ### **Key Companies in the US Single Photon Emission Computed Tomography Market Include** ## **US Single Photon Emission Computed Tomography Market Industry Developments** The US Single Photon Emission Computed Tomography (SPECT) Market has experienced notable developments, particularly concerning mergers and acquisitions. In August 2023, Siemens Healthineers announced the acquisition of a specialized imaging software company to enhance its portfolio in nuclear medicine, impacting its growth trajectory significantly. Several reports from reliable industry sources indicated increasing market valuation for companies such as Koninklijke Philips N.V. and General Electric due to technological advancements and demand for enhanced imaging capabilities. The integration of artificial intelligence in imaging equipment has become a focal point for innovation among companies like Canon Medical Systems and Toshiba Medical Systems, driving market growth. Additionally, Brilliance Health and Radiological Imaging Technology have been expanding their service offerings to meet the rising healthcare demands in the US. Over the last couple of years, the market has seen robust growth, with particular emphasis on research and development initiatives aimed at improving SPECT imaging accuracy, as highlighted in reports from the US Food and Drug Administration and National Institutes of Health that trace back to developments from 2021 onwards, contributing to a competitive and dynamic market environment. ## **US Single Photon Emission Computed Tomography Market Segmentation Insights** ### **Single Photon Emission Computed Tomography Market Type Outlook** ### **Single Photon Emission Computed Tomography Market Application Outlook** ### **Single Photon Emission Computed Tomography Market End User Outlook** ## Market Drivers ### Growing Geriatric Population The increasing geriatric population in the US is a significant factor driving the single photon-emission-computed-tomography market. As individuals age, they are more susceptible to various health issues, including neurological disorders and cardiovascular diseases, which require advanced imaging for diagnosis and management. The US Census Bureau projects that by 2030, approximately 20% of the population will be aged 65 and older. This demographic shift is likely to escalate the demand for diagnostic imaging services, including single photon-emission-computed-tomography, as healthcare providers strive to cater to the unique needs of older patients. ### Rising Healthcare Expenditure The upward trend in healthcare expenditure in the US is contributing to the growth of the single photon-emission-computed-tomography market. With healthcare spending projected to reach $6 trillion by 2027, there is a corresponding increase in investment in advanced diagnostic technologies. This financial commitment enables healthcare facilities to acquire state-of-the-art imaging equipment, including single photon-emission-computed-tomography systems. As hospitals and clinics allocate more resources towards enhancing diagnostic capabilities, the market is likely to experience robust growth, driven by the demand for high-quality imaging solutions. ### Enhanced Focus on Preventive Healthcare There is a growing emphasis on preventive healthcare in the US, which is positively impacting the single photon-emission-computed-tomography market. As healthcare providers and patients alike recognize the importance of early detection and intervention, the demand for advanced imaging techniques is increasing. Single photon-emission-computed-tomography plays a crucial role in screening and monitoring various health conditions, thereby aligning with the preventive healthcare paradigm. This shift towards proactive health management is expected to drive market growth, as more individuals seek out diagnostic imaging services to identify potential health issues before they escalate. ### Increasing Prevalence of Chronic Diseases The rising incidence of chronic diseases such as cardiovascular disorders and cancer in the US is a primary driver for the single photon-emission-computed-tomography market. As these conditions become more prevalent, the demand for advanced diagnostic imaging techniques increases. According to recent statistics, chronic diseases account for approximately 70% of all deaths in the US, necessitating effective diagnostic tools. Single photon-emission-computed-tomography offers precise imaging capabilities that aid in early detection and treatment planning. This growing need for accurate diagnostics is likely to propel the market forward, as healthcare providers seek to enhance patient outcomes through advanced imaging technologies. ### Technological Innovations in Imaging Techniques Technological advancements in imaging modalities are significantly influencing the single photon-emission-computed-tomography market. Innovations such as improved detector technologies, enhanced image reconstruction algorithms, and the integration of artificial intelligence are transforming the landscape of diagnostic imaging. These advancements not only improve image quality but also reduce scan times, making procedures more efficient. The market is projected to witness a growth rate of around 8% annually, driven by these innovations. As healthcare facilities adopt cutting-edge technologies, the demand for single photon-emission-computed-tomography systems is expected to rise, reflecting a shift towards more sophisticated diagnostic solutions. ## Future Outlook The single photon-emission-computed-tomography market is projected to grow at a 6.9% CAGR from 2025 to 2035, driven by technological advancements and increasing diagnostic applications. **New opportunities:** - Development of AI-driven imaging software for enhanced diagnostic accuracy. - - Expansion of mobile SPECT units for remote healthcare services. - Partnerships with pharmaceutical companies for radiopharmaceutical supply chains. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare demands. ## Segment Insights ### By Type: Hybrid SPECT Systems (Largest) vs. Standalone SPECT System (Fastest-Growing) The US single photon-emission-computed-tomography market shows a considerable distribution of market share between Hybrid SPECT Systems and Standalone SPECT Systems. Hybrid SPECT Systems dominate this segment, capturing a significant portion of the market owing to their advanced imaging capabilities and integration with other modalities. Meanwhile, Standalone SPECT Systems represent a growing share, appealing particularly to facilities looking for specific diagnostic tools without the need for integration. Growth trends within this segment reveal a strong inclination towards Hybrid SPECT Systems, primarily driven by technological advancements and increasing consumer demand for multi-functional imaging solutions. The Standalone SPECT System is emerging rapidly, fueled by its appeal in outpatient settings and cost-effective offerings. The rise in awareness of SPECT technology and improving healthcare infrastructure further bolster the growth of these systems, indicating a dynamic future for both segment values. System Type: Hybrid SPECT Systems (Dominant) vs. Standalone SPECT System (Emerging) Hybrid SPECT Systems are characterized by their ability to provide advanced imaging through the combination of SPECT with other technologies, such as CT or MRI, allowing for improved diagnostic accuracy and functionality. Currently, they hold a dominant position in the market due to their versatility and comprehensive imaging capabilities. In contrast, Standalone SPECT Systems are positioned as a cost-effective and efficient option, particularly beneficial for diagnostic imaging centers that focus on specific applications. While they are emerging as a significant choice for many healthcare facilities, driven by their ease of use and independence from other systems, they still account for a smaller segment of the overall market. The differentiation between these two types drives competition and innovation within the market. ### By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing) In the US single photon-emission-computed-tomography market, the application segments are dynamically distributed among oncology, cardiology, and neurology. Oncology represents the largest share, attributed to the growing prevalence of cancer and the increasing adoption of advanced imaging techniques for diagnosis and treatment planning. Meanwhile, cardiology, while smaller in share, exhibits robust growth due to rising cardiovascular diseases and the heightened focus on early detection and management. The growth trends within these segments are driven by technological advancements and increasing healthcare expenditure. Oncology continues to dominate the market as innovations in imaging technology improve accuracy and treatment outcomes. Cardiology is positioned as the fastest-growing segment, fueled by emerging techniques and an aging population that demands better diagnostic solutions, thus creating significant opportunities for growth in the coming years. Oncology (Dominant) vs. Cardiology (Emerging) In the US [single photon-emission-computed-tomography market](https://www.marketresearchfuture.com/reports/single-photon-emission-computed-tomography-market-7231), oncology stands as the dominant application due to its critical role in cancer detection and treatment monitoring. With advanced imaging techniques allowing for precise tumor localization, oncology applications are extensively utilized in clinical settings. Conversely, cardiology is emerging as a vital segment, leveraging innovations in imaging technology to facilitate early diagnosis of heart conditions. This segment is witnessing an upward trend as healthcare providers seek efficient solutions for managing the increasing incidence of cardiovascular diseases. The rapid advancements tailored for cardiology are not only elevating its market presence but also reinforcing the necessity for comprehensive imaging solutions across various medical fields. ### By End-User: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing) In the US single photon-emission-computed-tomography market, hospitals hold a dominant share, driven by the increasing patient admissions and the need for advanced diagnostic solutions. This segment capitalizes on integrated imaging services, catering to a wide array of medical specialties, thus maintaining its leading market position. On the other hand, diagnostic imaging centers are emerging rapidly, catering to a growing demand for specialized imaging services and outpatient care, driven by technological advancements and evolving patient preferences. The growth trends in this segment are influenced by factors such as increased healthcare spending and an aging population that requires early disease detection. Moreover, advancements in SPECT technology are enabling imaging centers to offer more reliable and accurate diagnostic services. As these centers focus on convenience and accessibility, they are becoming a preferred choice for patients, thereby gaining momentum in the market. Hospitals (Dominant) vs. Diagnostic Imaging Centers (Emerging) Hospitals represent the dominant end-user segment in the US single photon-emission-computed-tomography market, equipped with advanced infrastructure and comprehensive healthcare services. They benefit from a robust network of specialists and a greater volume of patient referrals, allowing them to utilize SPECT technology effectively in various clinical applications. Conversely, diagnostic imaging centers are emerging as key players, leveraging their ability to provide focused services and flexible scheduling options. These centers are increasingly adopting cutting-edge SPECT technologies, enhancing their diagnostic capabilities and patient throughput. Their appeal lies in lower wait times and personalized care, making them an attractive alternative for patients seeking reliable imaging services while also experiencing significant growth due to demand for outpatient diagnostics. ## Competitive Benchmarking The single photon-emission-computed-tomography market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic imaging. Key players such as Siemens Healthineers (Germany), GE Healthcare (UK), and Philips Healthcare (Netherlands) are at the forefront, each adopting distinct strategies to enhance their market presence. Siemens Healthineers (Germany) emphasizes innovation through the development of advanced imaging technologies, while GE Healthcare (UK) focuses on strategic partnerships to expand its product offerings. Philips Healthcare (Netherlands) is investing heavily in digital transformation, aiming to integrate AI capabilities into its imaging systems, thereby enhancing diagnostic accuracy and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological differentiation and customer-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to emerge, yet the collective strength of major companies shapes the overall competitive dynamics, fostering an environment where innovation and strategic collaborations are paramount. In October Siemens Healthineers (Germany) announced the launch of its latest SPECT imaging system, which integrates AI algorithms to improve image quality and reduce scan times. This strategic move is likely to position Siemens as a leader in the market, as it addresses the growing demand for faster and more accurate diagnostic tools. The incorporation of AI not only enhances the user experience but also aligns with broader trends towards digitalization in healthcare. In September GE Healthcare (UK) entered a partnership with a leading telehealth provider to enhance remote diagnostic capabilities using SPECT technology. This collaboration is significant as it reflects a shift towards integrated healthcare solutions, allowing for real-time data sharing and improved patient outcomes. By leveraging telehealth, GE Healthcare is likely to expand its market reach and cater to the evolving needs of healthcare providers. In August Philips Healthcare (Netherlands) unveiled a new software platform designed to streamline the workflow of SPECT imaging, incorporating cloud-based analytics. This initiative underscores Philips' commitment to digital transformation and positions the company to capitalize on the growing trend of data-driven healthcare. The platform is expected to enhance operational efficiency and provide healthcare professionals with actionable insights, thereby improving patient care. As of November the competitive trends in the single photon-emission-computed-tomography market are increasingly defined by digitalization, sustainability, and AI integration. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and supply chain reliability. This shift suggests that companies that prioritize R&D and strategic partnerships will be better positioned to thrive in an increasingly complex market. ## Recent News & Developments The US Single Photon Emission Computed Tomography (SPECT) Market has experienced notable developments, particularly concerning mergers and acquisitions. In August 2023, Siemens Healthineers announced the acquisition of a specialized imaging software company to enhance its portfolio in nuclear medicine, impacting its growth trajectory significantly. Several reports from reliable industry sources indicated increasing market valuation for companies such as Koninklijke Philips N.V. and General Electric due to technological advancements and demand for enhanced imaging capabilities. The integration of artificial intelligence in imaging equipment has become a focal point for innovation among companies like Canon Medical Systems and Toshiba Medical Systems, driving market growth. Additionally, Brilliance Health and Radiological Imaging Technology have been expanding their service offerings to meet the rising healthcare demands in the US. Over the last couple of years, the market has seen robust growth, with particular emphasis on research and development initiatives aimed at improving SPECT imaging accuracy, as highlighted in reports from the US Food and Drug Administration and National Institutes of Health that trace back to developments from 2021 onwards, contributing to a competitive and dynamic market environment. ## Report Scope | MARKET SIZE 2024 | 419.06(USD Million) | | --- | --- | | MARKET SIZE 2025 | 447.98(USD Million) | | MARKET SIZE 2035 | 873.21(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Siemens Healthineers (DE), GE Healthcare (GB), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Mediso Medical Imaging Systems (HU), Spectrum Dynamics Medical (US), Zebra Medical Vision (IL) | | Segments Covered | Type, Application, End-User | | Key Market Opportunities | Advancements in imaging technology enhance diagnostic accuracy in the single photon-emission-computed-tomography market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the single photon-emission-computed-tomography market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US single photon-emission-computed-tomography market in 2024?** A: The market valuation was $419.06 Million in 2024. **Q: What is the projected market valuation for the US single photon-emission-computed-tomography market by 2035?** A: The projected valuation for 2035 is $873.21 Million. **Q: What is the expected CAGR for the US single photon-emission-computed-tomography market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 6.9%. **Q: Which companies are considered key players in the US single photon-emission-computed-tomography market?** A: Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Elekta, Mediso Medical Imaging Systems, Spectrum Dynamics Medical, and Zebra Medical Vision. **Q: What are the two main types of systems in the US single photon-emission-computed-tomography market?** A: The two main types are Hybrid SPECT Systems and Standalone SPECT Systems. **Q: What was the market value for Hybrid SPECT Systems in 2024?** A: The market value for Hybrid SPECT Systems was $251.06 Million in 2024. **Q: What is the projected market value for Standalone SPECT Systems by 2035?** A: The projected market value for Standalone SPECT Systems by 2035 is $343.0 Million. **Q: Which application segment had the highest market value in 2024?** A: The Cardiology application segment had the highest market value at $150.0 Million in 2024. **Q: What is the projected market value for the Neurology application segment by 2035?** A: The projected market value for the Neurology application segment by 2035 is $363.21 Million. **Q: Which end-user segment is expected to show significant growth in the US single photon-emission-computed-tomography market?** A: The Hospitals end-user segment is expected to show significant growth, with a value of $546.21 Million projected by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-single-photon-emission-computed-tomography-market-19725*